Context

In the time of epidemics, what is the status of HIV AIDS across the world, where does each country stands, is it getting any better. The data set should be helpful to explore much more about above mentioned factors.

Content

The data set contains data on

1. No. of people living with HIV AIDS
2. No. of deaths due to HIV AIDS
3. No. of cases among adults (19-45)
4. Prevention of mother-to-child transmission estimates
5. ART (Anti Retro-viral Therapy) coverage among people living with HIV estimates
6. ART (Anti Retro-viral Therapy) coverage among children estimates

Acknowledgements / Data Source

• WHO : https://www.who.int/hiv/data/en/
• UNESCO : https://data.unicef.org/resources/dataset/hiv-aids-statistical-tables/

Collection methodology

https://github.com/imdevskp/hiv_aids_who_unesco_data_cleaning

Cover Photo

Photo by Anna Shvets from Pexels https://www.pexels.com/photo/red-ribbon-on-white-surface-3900425/

Similar Datasets

• COVID-19 - https://www.kaggle.com/imdevskp/corona-virus-report
• MERS - https://www.kaggle.com/imdevskp/mers-outbreak-dataset-20122019
• Ebola Western Africa 2014 Outbreak - https://www.kaggle.com/imdevskp/ebola-outbreak-20142016-complete-dataset
• H1N1 | Swine Flu 2009 Pandemic Dataset - https://www.kaggle.com/imdevskp/h1n1-swine-flu-2009-pandemic-dataset
• SARS 2003 Pandemic - https://www.kaggle.com/imdevskp/sars-outbreak-2003-complete-dataset
• HIV AIDS - https://www.kaggle.com/imdevskp/hiv-aids-dataset

United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.500 % in 2014. This stayed constant from the previous number of 0.500 % for 2013. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.500 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.500 % in 2014 and a record low of 0.500 % in 2014. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

Analysis of ‘HIV AIDS Dataset’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://www.kaggle.com/imdevskp/hiv-aids-dataset on 13 February 2022.

--- Dataset description provided by original source is as follows ---

Context

In the time of epidemics, what is the status of HIV AIDS across the world, where does each country stands, is it getting any better. The data set should be helpful to explore much more about above mentioned factors.

Content

The data set contains data on

1. No. of people living with HIV AIDS
2. No. of deaths due to HIV AIDS
3. No. of cases among adults (19-45)
4. Prevention of mother-to-child transmission estimates
5. ART (Anti Retro-viral Therapy) coverage among people living with HIV estimates
6. ART (Anti Retro-viral Therapy) coverage among children estimates

Acknowledgements / Data Source

• WHO : https://www.who.int/hiv/data/en/
• UNESCO : https://data.unicef.org/resources/dataset/hiv-aids-statistical-tables/

Collection methodology

https://github.com/imdevskp/hiv_aids_who_unesco_data_cleaning

Cover Photo

Photo by Anna Shvets from Pexels https://www.pexels.com/photo/red-ribbon-on-white-surface-3900425/

Similar Datasets

• COVID-19 - https://www.kaggle.com/imdevskp/corona-virus-report
• MERS - https://www.kaggle.com/imdevskp/mers-outbreak-dataset-20122019
• Ebola Western Africa 2014 Outbreak - https://www.kaggle.com/imdevskp/ebola-outbreak-20142016-complete-dataset
• H1N1 | Swine Flu 2009 Pandemic Dataset - https://www.kaggle.com/imdevskp/h1n1-swine-flu-2009-pandemic-dataset
• SARS 2003 Pandemic - https://www.kaggle.com/imdevskp/sars-outbreak-2003-complete-dataset
• HIV AIDS - https://www.kaggle.com/imdevskp/hiv-aids-dataset

--- Original source retains full ownership of the source dataset ---

This dataset contains surveillance study estimates for population size, HIV prevalence, and ART coverage among female sex workers (FSW), men who have sex with men (MSM), people who inject drugs (PWID), and transgender men and women (TGM/W) from 2010-2023. It was created to support the UNAIDS Estimates Key Population Workbook for use by HIV estimates teams in sub-Saharan Africa. Key population surveillance reports, including Ministry of Health-led biobehavioural surveys, mapping studies, and academic studies were used to populate the database.

The dataset was populated using existing key population size estimate databases including:

UNAIDS Key Population Atlas

US Centers for Disease Control and Prevention surveillance database

Global Fund against HIV/AIDS, TB, and Malaria surveillance database

Global.HIV database

Systematic review databases among MSM (Stannah et al, 2019 and Stannah et al., 2023) and PWID (Degenhardt et al., 2023)

and was additionally supplemented by a literature review of peer-reviewed and grey literature sources.

The data can be explored in this web application and the accompanying manuscript can be found here

Since the People Living with HIV Stigma Index was launched in 2008, shifts in the HIV epidemic, growth in the evidence base on how different populations are affected by stigma, and changes in the global response to HIV — particularly given the recommendation of early initiation of treatment — have highlighted the need to update and strengthen the Stigma Index as a measurement and advocacy tool. In October 2015, with support from USAID/PEPFAR, Project SOAR established a small working group (SWG) with representatives from the Global Network of People Living with HIV (GNP+), the International Community of Women Living with HIV (ICW), the Joint United Nations Programme on HIV/AIDS (UNAIDS), USAID, and several experts within and external to SOAR. The SWG outlined a process for evaluating and updating the Stigma Index that would be transparent and incorporate as many perspectives as possible in the process. The updated draft survey was then formally pilot-tested before being finalized and disseminated in late 2017.

Cuba CU: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.600 % in 2022. This stayed constant from the previous number of 0.600 % for 2021. Cuba CU: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.200 % from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 0.600 % in 2022 and a record low of 0.100 % in 2003. Cuba CU: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Cuba – Table CU.World Bank.WDI: Social: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.;UNAIDS estimates.;Weighted average;

Global Network of People Living with HIV (GNP+) Activity File

PrEP is the use of an antiretroviral medication by people who are uninfected to prevent the acquisition of HIV. The efficacy of PrEP has been shown in a number of randomised controlled trials including iPREX, Partners PrEP, PROUD and ANRS-IPERGAY. In 2015, the European Centre for Disease Prevention and Control (ECDC) recommended that European Union (EU) and European Economic Area (EEA) countries should consider integrating PrEP into their existing HIV prevention package for those most at risk of HIV infection, starting with men who have sex with men (MSM). This was followed by the World Health Organization (WHO) recommendations that PrEP should be offered as an additional prevention option to all people at substantial risk of HIV infection as part of combination prevention approaches. As a result, several countries in the EU/EEA have either implemented PrEP or are considering options for implementation. Since the 1st of June 2017, PrEP is nationally available in Belgium and reimbursed for people who are at increased risk for HIV acquisition. Belgium is one of the countries in Europe reporting a high HIV incidence, with 8.1 new HIV infections per 100 000 inhabitants in 2019.The epidemic mainly affects two populations: men who have sex with men (MSM) and Sub-Saharan African migrants, most of whom have acquired HIV through unprotected heterosexual contacts. A recent study suggests that ongoing clustered transmission in Belgium is almost exclusively driven by MSM. As the national PrEP program is brought to scale, the need for a robust monitoring system emerges. An effective PrEP program is one in which people in greatest need of HIV prevention are appropriately identified, offered PrEP, and then continue to receive continued support to use PrEP as needed. Monitoring PrEP program implementation is therefore important to (1) track progress in uptake and coverage among the eligible population, (2) estimate impact on the HIV epidemic, and (3) inform the strategic planning of the program (e.g. cost, resources, supply of commodities).

Malawi MW: Antiretroviral Therapy Coverage: % of People Living with HIV data was reported at 71.000 % in 2017. This records an increase from the previous number of 66.000 % for 2016. Malawi MW: Antiretroviral Therapy Coverage: % of People Living with HIV data is updated yearly, averaging 20.500 % from Dec 2000 (Median) to 2017, with 18 observations. The data reached an all-time high of 71.000 % in 2017 and a record low of 0.000 % in 2003. Malawi MW: Antiretroviral Therapy Coverage: % of People Living with HIV data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Malawi – Table MW.World Bank.WDI: Health Statistics. Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.; ; UNAIDS estimates.; Weighted average;

In 2021, 1.9 million people in Nigeria were living with HIV. Women were the most affected group, counting 1.1 thousand individuals. Also, children up to age 14 who were HIV positive equaled 170 thousand.

Sweden SE: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.200 % in 2016. This stayed constant from the previous number of 0.200 % for 2015. Sweden SE: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.100 % from Dec 1990 (Median) to 2016, with 27 observations. The data reached an all-time high of 0.200 % in 2016 and a record low of 0.100 % in 2010. Sweden SE: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Sweden – Table SE.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted average;

BackgroundAs the life expectancy of people living with human immunodeficiency virus (HIV) (PLWH) has improved, chronic disease burden and polypharmacy have increased in PLWH. Simplification of the antiretroviral therapy (ART) regimen for PLWH has become crucial. The real-world treatment patterns and medication persistence of the 2-drug single-tablet regimen (STR), dolutegravir/lamivudine (DTG/3TC), compared to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) prescribed were investigated.MethodsThis retrospective, database study extracted data from a hospital-based medical claims database in Japan. The changes in ART distributions by year during the identification period between January 1, 2018 and December 31, 2021 were observed. Patients with disease record of HIV-1 infection and prescribed DTG/3TC or BIC/FTC/TAF as the first prescription of STR during the identification period were divided into two cohorts; DTG/3TC cohort and BIC/FTC/TAF cohort, respectively. Patient without medication records more than 3 months and no future data more than 6 months were excluded. Patients’ characteristics were compared between the DTG/3TC cohort and the BIC/FTC/TAF cohort by Mantel–Haenszel test to adjust for age. Medication persistence was compared between the two cohorts by evaluating the continuation rates using Kaplan–Meier methods, using the log-rank test to assess the difference between the Kaplan–Meier curves. The median time-to-first prescription was compared between the two cohorts by Kaplan–Meier methods.ResultsPrescriptions of DTG/3TC and BIC/FTC/TAF increased steadily from 2019 to 2021 after the release year of each STR. There was no significant difference in the time-to-first prescription (p = 0.3). A total of 959 patients were included, with 120 patients and 839 patients on DTG/3TC and BIC/FTC/TAF, respectively. The proportion of dyslipidemia at baseline was significantly higher in the DTG/3TC cohort than in the BIC/FTC/TAF cohort after adjusting for mean age (p = 0.002). There was no significant difference in medication persistence between the two cohorts (p = 0.91).ConclusionThis study showed that DTG/3TC was likely to be selected for elderly patients and those with chronic disease in real-world clinical practice, which seems in accordance with the treatment strategy recommended by guidelines. Comparable medication persistence was observed with both regimens, aligning with findings from other countries. The 2-drug single-tablet regimen DTG/3TC may be an important ART regimen for PLWH with multiple morbidities and polypharmacy in an aging society. Due to the limitations of the database, further research to assess viral loads, emergence of resistance and adverse events will be encouraged.

Montenegro ME: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.100 % in 2016. This stayed constant from the previous number of 0.100 % for 2015. Montenegro ME: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.100 % from Dec 1990 (Median) to 2016, with 27 observations. The data reached an all-time high of 0.100 % in 2016 and a record low of 0.100 % in 2016. Montenegro ME: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Montenegro – Table ME.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

Abstract

The study aim was to describe the roles and health issues of older people (50 years and older) who have offspring who are infected or deceased due to HIV, or who have HIV themselves. In addition the effects of the introduction of HIV treatment on the lives and wellbeing of people aged 50 and above was investigated. Specifically, the aims of the study were to describe the effects on physical and mental health, household income and social situation as well as the tasks and responsibilities of older people infected and/or affected by HIV.

Geographic coverage

Rural subdistrict Hlabisa, Kwa-Zulu Natal Province, South Africa

Analysis unit

individuals

Universe

Hlabisa, Africa Centre, Health and Demographic Surveillance Site fifty plus population

Kind of data

Sample survey data [ssd]

Sampling procedure

The sample was stratified into five groups. Group 1 was older people on HIV treatment for 1 year or more in 2010 at the time of Wave I of the project. Group 2 was older people who were not on HIV treatment or on treatment for 3 months or less in 2010 (Wave I). Group 3 was older people who had an adult (14-49 years) offspring in the household who was HIV-infected in 2010 (Wave 1). Group 4 was older people who had experienced an HIV-related death of an adult household member in 2010 (Wave 1). Group 5 was older people who were not on HIV treatment or were on treatment for 3 months or less in 2013 (at the time of Wave II). There was over sampling of participants in groups 2 and 5. A two-stage sampling process was adopted for participants in groups 1, 2 and 5. At stage one, all persons meeting the respective criteria for each group were identified from the Hlabisa treatment programme. At stage two, 100 participants for each group who are also under surveillance were randomly selected. The study is restricted to persons aged 50 and above and to those living in the Africa Centre surveillance area. The sample is representative of HIV-infected and HIV-affected older persons in the study population. Respondents who were absent, not found or refused were replaced with another randomly selected respondent meeting the same inclusion criteria. Sampling frame used was the Hlabisa HIV care and Treatment database (ARTeMIS) and the Africa Centre Longitudinal surveillance system. Participants in groups 1,2 and 5 were first identified from ARTeMIS then all those under surveillance and the specific criteria for each group were randomly selected and approached for participation.

Mode of data collection

Face-to-face [f2f]

Research instrument

The questionnaires for the Well-Being of Older People Study (WOPS) were based on the World Health Organization's Study on Global Ageing and Adult Health (SAGE) questionnaires, with some modifications and additions to suit the local environment. The questionnaires were also partially harmonized with a similar sub-study in Uganda. The study instrument has three main components: (1) detailed questionnaire on basic demographic information, description of health state including functional ability assessment, well-being, health problems and symptoms, health care utilisation, care giving and care receiving, and experiences of living with HIV (2) collection of anthropometry data (3) blood sample for laboratory measured health risk biomarkers

Cleaning operations

Data editing and quality control was conducted at three levels. 1. During field work the professional nurses cross checked their forms for incomplete or missing information. 2. The two co-principal investigators checked each form for completeness and quality of data. 3. Data entry constraints were built into the data entry programme to spot errors and inconsistencies. Any errors identified at any of these stages were referred back to the professional nurses who revisited the participant for data correction.

Iraq Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.100 % in 2022. This stayed constant from the previous number of 0.100 % for 2021. Iraq Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.100 % from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 0.100 % in 2022 and a record low of 0.100 % in 2022. Iraq Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Iraq – Table IQ.World Bank.WDI: Social: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.;UNAIDS estimates.;Weighted average;

LT: Female Adults with HIV: % of Population Aged 15+ with HIV data was reported at 29.567 % in 2016. This records an increase from the previous number of 29.543 % for 2015. LT: Female Adults with HIV: % of Population Aged 15+ with HIV data is updated yearly, averaging 29.293 % from Dec 1990 (Median) to 2016, with 27 observations. The data reached an all-time high of 30.084 % in 2009 and a record low of 23.215 % in 1990. LT: Female Adults with HIV: % of Population Aged 15+ with HIV data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Lithuania – Table LT.World Bank: Health Statistics. Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.; ; UNAIDS estimates.; Weighted average;

Nigeria NG: Antiretroviral Therapy Coverage: % of People Living with HIV data was reported at 33.000 % in 2017. This records an increase from the previous number of 31.000 % for 2016. Nigeria NG: Antiretroviral Therapy Coverage: % of People Living with HIV data is updated yearly, averaging 9.000 % from Dec 2000 (Median) to 2017, with 18 observations. The data reached an all-time high of 33.000 % in 2017 and a record low of 0.000 % in 2002. Nigeria NG: Antiretroviral Therapy Coverage: % of People Living with HIV data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Nigeria – Table NG.World Bank.WDI: Health Statistics. Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.; ; UNAIDS estimates.; Weighted average;

IT: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.300 % in 2016. This stayed constant from the previous number of 0.300 % for 2015. IT: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.300 % from Dec 1990 (Median) to 2016, with 27 observations. The data reached an all-time high of 0.300 % in 2016 and a record low of 0.100 % in 1991. IT: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Italy – Table IT.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

Morocco MA: Female Adults with HIV: % of Population Aged 15+ with HIV data was reported at 38.900 % in 2017. This records an increase from the previous number of 38.700 % for 2016. Morocco MA: Female Adults with HIV: % of Population Aged 15+ with HIV data is updated yearly, averaging 37.350 % from Dec 1990 (Median) to 2017, with 28 observations. The data reached an all-time high of 40.200 % in 1990 and a record low of 35.900 % in 1997. Morocco MA: Female Adults with HIV: % of Population Aged 15+ with HIV data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Morocco – Table MA.World Bank.WDI: Health Statistics. Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.; ; UNAIDS estimates.; Weighted average;

Bahamas BS: Female Adults with HIV: % of Population Aged 15+ with HIV data was reported at 48.196 % in 2022. This records a decrease from the previous number of 48.355 % for 2021. Bahamas BS: Female Adults with HIV: % of Population Aged 15+ with HIV data is updated yearly, averaging 44.995 % from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 48.462 % in 2018 and a record low of 43.469 % in 1990. Bahamas BS: Female Adults with HIV: % of Population Aged 15+ with HIV data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Bahamas – Table BS.World Bank.WDI: Social: Health Statistics. Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.;UNAIDS estimates.;Weighted average;